Press releases
- IQVIA to Announce Fourth-Quarter and Full-Year 2020 Results on February 10, 2021
- Laboratoires Théa Selects IQVIA OCE and OneKey to Accelerate Its Global Digital Transformation
- Q² Solutions, an IQVIA and Quest Diagnostics Joint Venture, Teams With Adaptive Biotechnologies to Market immunoSEQ® Assay, the Leading Quantitative Large-Scale Immunosequencing Solution
- Prescription Opioid Use in the U.S. has Declined by 60% from 2011 Peak, According to New Report from the IQVIA™ Institute for Human Data Science
- IQVIA and Servier Collaborate to Reinvent Clinical Development
- IQVIA Supports Collaborative Forum of Top Pharma Leaders to Advance the Use and Acceptance of Real World Evidence
- IQVIA’s Orchestrated Customer Engagement Platform Selected by Zentiva to Accelerate Digital Capabilities
More ▼
Key statistics
Markit short selling activity
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 191.73m |
Free float | 189.70m |
P/E (TTM) | 203.81 |
Market cap | 35.09bn USD |
EPS (TTM) | 0.898 USD |
Data delayed at least 15 minutes.
More ▼